Skip to main content
Reimbursement strategy

Market Access Strategy for Medical Devices in Europe

Strategic recommendations on the topic of market access pathways for medical devices and IVD tests

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Dutch ZonMw is open for applications to the Care Evaluation and Appropriate Use program

On August 4, 2026, the Dutch Organization for Health Research and Development (ZonMw) opened applications for subsidy round 3 “Impactful knowledge questions in medical specialist care” under the Care Evaluation and Appropriate Use (2024–2028) program. The deadline for submitting a study synopsis, including a relevance dossier, is December 4, 2026. The deadline for submitting the full grant application is May 13, 2027.

The Care Evaluation and Appropriate Use (2024-2028) program (Zorgevaluatie en Gepast Gebruik, ZE&GG) aims to implement appropriate care by evaluating and implementing knowledge about what constitutes appropriate care. The results of care evaluations conducted within the program are expected to contribute to changes in medical practice. The program is a joint initiative of all parties involved in medical specialist care, with ZonMw and the Dutch Healthcare Institute (ZIN) serving as strategic partners.

The current subsidy round aims to answer important knowledge questions with substantial societal impact through care evaluation research. The round is linked to the continuous process of identifying and prioritizing knowledge gaps in medical specialist care. Knowledge questions may be proposed by the key stakeholders in medical specialist care, including the Federation of Medical Specialists (FMS), the Dutch Nurses and Caregivers (V&VN), Health Insurers Netherlands (ZN), and ZIN.

A grant application can be submitted only if the ZE&GG program has nominated the applicant, and the proposal has been developed through co-creation in accordance with the Cycle of Appropriate Use methodology.

The total subsidy budget available for this round is €8 million, with a maximum of €1.5 million available per project.

This news is just one of about 300 market access news and updates collected by our team in the premium subscription service MTRC Access Intelligence every week from more than 80 organizations. Access our paid service to stay on top of all developments, specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, six-week, no-obligation trial.